Pharmacophore development and 3D-QSAR study of I1 Imidazoline Binding Site ligands

Medicinal Chemistry Research

Volumn 13, Issue 3-4, 2004, Pages 170-189

  Nicolotti, Orazio ^a   Carotti, Angelo ^a   Carrieri, Antonio ^a   Pigini, Maria ^b   Gentili, Francesco ^b   Brasili, Livio ^c   Giannella, Mario ^b   Quaglia, Wilma ^b   Piergentili, Alessandro ^b   Bousquet, Pascal ^d   Dontenwill, Monique ^d  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 (1 METHYL 2 PHENYLETHYL) 4,5 DIHYDRO 1H IMIDAZOLE OXALATE; AMILORIDE; CLONIDINE; IMIDAZOLINE DERIVATIVE; IMIDAZOLINE I1 RECEPTOR; IMIDAZOLINE I2 RECEPTOR; LNP 509; MOXONIDINE; OXAZOLINE DERIVATIVE; PYRROLINE DERIVATIVE; RADIOLIGAND; RILMENIDINE; S 23515; S 23757; UNCLASSIFIED DRUG;

BINDING AFFINITY; CHIRALITY; COMPARATIVE MOLECULAR FIELD ANALYSIS; CONFERENCE PAPER; CORRELATION ANALYSIS; DRUG BINDING SITE; DRUG RECEPTOR BINDING; ELECTRICITY; LIGAND BINDING; PHARMACOPHORE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STEREOSPECIFICITY; SUBSTITUTION REACTION;

EID: 10644293878     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-004-0023-9     Document Type: Conference Paper

References (60)

1. Bousquet, P.; Feldman, J.; Schwartz, J. J. Pharmacol. Exp. Ther. 1984, 230, 232-236.
2. Molderings, G. J. Drugs Future 1997, 22, 757-772.
3. Michel, M. C.; Ernsberger, P. Trends Pharmacol. Sci. 1992, 13, 369-370.
4. Tesson, F.; Prib-Buus, C.; Lenoine, A.; Pegorier, J. P.; Parini, A. J. Biol. Chem. 1991, 266, 155-160.
5. Eglen, R. M.; Hudson, A. L.; Kendall, D. A.; Nutt, D. J.; Morgan, N. G.; Wilson, V. G.; Dillon, M. P. Trends Pharmacol. Sci. 1998, 19, 381-390.
6. Chu, T. C.; Socci, R. R.; Ogidigben, M. J.; Potter, E. D. J. Ocul. Pharmacol. Ther. 1997, 13, 489-496.
7. Ugedo, L.; Pineda, J.; Ruiz-Ortega, J. A.; Marfin-Ruiz, R. Br. J. Pharmacol. 1998, 125, 1685-1694.
8. Rondu, F.; Le Bihan, G.; Wang, X.; Lamouri, A.; Touboul, E.; Dive, G.; Bellahsene, T.; Pfeiffer, B.; Renard, P.; Guardiola-Lemaitre, B.; Manechez, D.; Penicaud, L.; Ktorza, A.; Godfroid, J. J. J. Med. Chem. 1997, 40, 3793-3803.
9. Chan, S. L. F. Gen. Pharmacol. 1998, 31, 525-529.
10. Emsberger, P.; Ishizuka, T.; Liu, S.; Farrell, C. J.; Bedol, D.; Koletsky, R. J.; Friedman, J. E. J. Pharmacol. Exp. Ther. 1999, 288, 139-147.
11. García-Sevilla, J. A.; Escriba, P. V.; Walzer, C.; Bouras, C.; Guimon, J. Neurosci. Lett. 1998, 247, 95-98.
12. Heemskerk, F. M. J.; Dontenwill, M.; Greney, H.; Vonthron, C.; Bousquet, P. J. Neurochem. 1998, 71, 2193-2201.
13. Nutt, D. J.; French, N.; Handley, S.; Hudson, A.; Husbands, S.; Jackson, H.; Jordan, S.; Lalies, M. D.; Lewis, J.; Lione, L.; Mallard, N.; Pratt, J. Ann. N. Y. Acad. Sci. 1995, 763, 125-139.
14. Polidori, C.; Gentili, F.; Pigini, M.; Quaglia, W.; Panocka, I.; Massi, M. Eur. J. Pharmacol. 2000, 392, 41-49.
15. Molderings, G. J.; Donecker, K.; Burian, M.; Simon, W. A.; Schroder, D. W.; Gothert, M. J. Pharmacol. Exp. Ther. 1998, 285, 170-177.
16. Ivanov, T. R.; Feng, Y.; Wang, H.; Regunathan, S.; Reis, D. J.; Chikkala, D. N.; Gupta, P.; Jones, J. C.; Piletz, J. E. J. Psychiatr. Res. 1998, 32, 65-79.
17. Boronat, M. A.; Olmos, G.; Garcia-Sevilla, J. A. Br. J. Pharmacol. 1998, 125, 175-185.
18. Smyth, D. D.; Penner, S. B. J. Auton. Nerv. Syst. 1998, 72, 155-162.
19. Gargalidis-Moudanos, C., Pizzinat, N.; Javoy-Agid, F.; Remaury, A.; Parini, A. Neurochem. Int. 1997, 30, 31-36.
20. Emsberger, P.; Friedman, J. E.; Koletsky, R. J. J. Hypertens. 1997, 15, S9-S23.
21. Wenzel, R. R.; Spieker, L.; Qui, S.; Shaw, S.; Luscher, T. F.; Noll, G. Hypertension 1998, 32, 1022-1027.
22. Molderings, G. J.; Gothert, M. Gen. Pharmacol. 1999, 32, 17-22.
23. Bousquet, P.; Feldman, J. Drugs 1999, 58, 799-812.
24. Schann, S.; Bruban, V.; Pompermayer, K.; Feldman, J.; Pfeiffer, B.; Renard, P.; Scalbert, E.; Bousquet, P.; Ehrhardt, J.-D. J. Med. Chem. 2001, 44, 1588-1593.
25. Bruban, V.; Feldman, J.; Greney, H.; Dontenwill, M.; Schann, S.; Jarry, C.; Payard, M.; Boutin, J.; Scalbert, E.; Pfeiffer, B.; Renard, P.; Vanhoutte, P.; Bousquet, P. Brit. J. Pharmacol. 2001, 133, 261-266.
26. Gentili, F.; Bousquet, P.; Brasili, L.; Dontenwill, M.; Feldman, J.; Ghelfi, F.; Giannella, M.; Piergentili, A.; Quaglia, W.; Pigini, M. J. Med. Chem. 2003, 46, 2169-2176.
27. Szabo, B. Pharmacol. Ther. 2002, 93, 1-35.
28. Carrieri, A.; Brasili, L.; Leonetti, F.; Pigini, M.; Giannella, M.; Bousquet, P.; Carotti, A. Bioorg. Med. Chem. 1997, 5, 843-856.
29. Pigini, M.; Bousquet, P.; Carotti, A.; Dontenwill, M.; Giannella, M.; Moriconi, R.; Piergentili, A.; Quaglia, W.; Tayebati, S. K.; Brasili, L. Bioorg. Med. Chem. 1997, 5, 833-841.
30. Pigini, M.; Bousquet, P.; Brasili, L.; Carrieri, A.; Cavagna, R.; Dontenwill, M.; Gentili, F.; Giannella, M.; Leonetti, F.; Piergentili, A.; Quaglia, W.; Carotti, A. Bioorg. Med. Chem. 1998, 6, 2245-2260.
31. Quaglia, W.; Bousquet, P.; Pigini, M.; Carotti, A.; Carrieri, A.; Dontenwill, M.; Gentili, F.; Giannella, M.; Maranca, F.; Piergentili, A.; Brasili, L. J. Med. Chem. 1999, 15, 2737-2740.
32. Separovic, D.; Kester, M.; Ernsberger, P. Mol. Pharmacol. 1996, 49, 668-675.
33. Livingstone, D. Data Analysis for Chemists. Oxford Science Publications: Oxford, 1995.
34. Kubinyi, H. QSAR: Hansch Analysis and Related Approaches. VCH: Weinheim, 1993.
35. Dunn, III, W. J.; Wold, S.; Edlund, U.; Helberg, S.; Gasteiger, J. Quant. Struct.-Act. Relat. 1984, 3, 131-137.
36. Cramer, R.D.; Patterson, D.E.; Bunce, J. D. J. Amer. Chem. Soc. 1988, 110, 5959-5967.
37. Goodford, P.J. J. Med. Chem. 1985, 28, 849-857.
38. Baroni, M.; Costantino, G.; Cruciani, G.; Riganelli, D.; Valigi, R.; Clementi, S. Quant. Struct.-Act. Relat, 1993, 12, 9-20.
39. Guner, F.O. Pharmacophore Perception, Development and Use in Drug Design, IUL Biotechnology Series: La Jolla, CA-USA, 2000.
40. http://www.daylight.com/smiles/f_smiles.html.
41. Todeschini, R.; Consonni, V.; Pavan, M. Dragon, Version 2.1, Talete s.r.1., Milano (Italy), 2002.
42. McFarland, J. W.; Gans, D. J. Quant. Struct.-Act. Relat. 1994, 13, 11-17.
43. Nicolotti, O.; Gillet, V. J.; Fleming, P. J.; Green, D. V. J. Med. Chem. 2002, 45, 5069-5080.
44. Nicolotti, O. Multi-Genetic-Zoom, Version 1.0, University of Bari (Italy), 2003.
45. Rogers, D. R.; Hopfinger, A. J. Chem. Inf Comput. Sci. 1994, 34, 854-866.
46. Todeschini, R; Consonni V. Handbook of molecular descriptors. WILEY-VCH: Weinheim, 2000.
47. Winkler, D.A.; Burden, F. R. Quant. Struct.-Act. Relat. 1998, 17, 224-231.
48. Clark, R.D.; Sprous, D.G.; Leonard, J.M. Rational Approaches to Drug Design; Höltje, H.D.; Sippl, W. Eds. Prous Science, SA, 2001, pp 475-485.
49. Wold, S.; Johansson, E.; Cocchi, M. 3D QSAR in Drug Design: Theory, Methods and Applications. Kubinyi, H., Ed.; Escom, Leiden, 1993, pp 523-549.
50. Thibaut, U. 3D QSAR in Drug Design: Theory, Methods and Applications. Kubinyi, H., Ed.; Escom, Leiden, 1993, pp 661-696.
51. MOPAC 6.0 is available from QCPE (506)
52. Carpy, A.; Leger, J. M.; Leclerc, G.; Decker, N.; Rouot, B.; Wermuth, C. G. Mol. Pharmacol. 1982, 21, 400-408.
53. Eriksson, L.; Johansson, E.; Kettaneh-Wold, N.; Wold, S. Multi- and Megavariate Data Analysis. Umetrics Academy: Umea, 2002.
54. Gaillard, P.; Carrupt, P.A.; Testa, B.; Boudon, A. J. Comput. Aided Mol. Des. 1994, 8, 83-96.
55. Baurin, N.; Vangrevelinghe, E.; Morin-Allory, L.; Merour, J. Y.; Renard, P.; Payard, M.; Guillaumet, G.; Marot, C. J. Med. Chem. 2000, 43, 1109-1122.
56. Willett, P.; Barnard, J. M.; Downs, G. M. J. Chem. Inf Comput. Sci. 1998, 38, 983-996.
57. Catalyst, Version 4.7, Accelrys Inc., San Diego, 2002.
58. Brooks, B.R; Bruccoleri, R. E; Olafson, B.D; States, D. J; Swaminathan, S; Karplus, M. J. Comp. Chem. 1983, 4, 187-217.
59. Smellie, A.; Teig, S.L.; Towbin, P. J. Comp. Chem., 1995, 16, 171-187.
60. ACD/Labs package, Release 7.0, Advanced Chemistry Development Inc. Toronto.